Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 11 studies | 34% ± 11% | |
oligodendrocyte precursor cell | 10 studies | 47% ± 16% | |
glutamatergic neuron | 9 studies | 41% ± 18% | |
GABAergic neuron | 8 studies | 39% ± 16% | |
endothelial cell | 8 studies | 42% ± 11% | |
pericyte | 6 studies | 45% ± 14% | |
mesothelial cell | 6 studies | 56% ± 13% | |
neuron | 5 studies | 34% ± 14% | |
interneuron | 5 studies | 42% ± 28% | |
type I pneumocyte | 5 studies | 38% ± 8% | |
hepatocyte | 4 studies | 58% ± 28% | |
astrocyte | 4 studies | 45% ± 19% | |
smooth muscle cell | 4 studies | 31% ± 10% | |
hepatic stellate cell | 3 studies | 48% ± 22% | |
progenitor cell | 3 studies | 40% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 9 studies | 31% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 77% | 323.62 | 2038 / 2642 | 94% | 6.28 | 666 / 705 |
liver | 100% | 744.78 | 225 / 226 | 67% | 2.54 | 271 / 406 |
thymus | 99% | 811.84 | 645 / 653 | 43% | 1.10 | 259 / 605 |
ovary | 100% | 2000.49 | 180 / 180 | 27% | 0.84 | 116 / 430 |
kidney | 66% | 203.19 | 59 / 89 | 60% | 4.19 | 544 / 901 |
lung | 98% | 497.24 | 564 / 578 | 19% | 0.55 | 217 / 1155 |
blood vessel | 99% | 1544.70 | 1327 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 78% | 658.58 | 1125 / 1445 | 19% | 0.60 | 35 / 183 |
adipose | 93% | 639.46 | 1115 / 1204 | 0% | 0 | 0 / 0 |
bladder | 86% | 379.24 | 18 / 21 | 5% | 0.17 | 27 / 504 |
prostate | 73% | 324.21 | 180 / 245 | 15% | 0.26 | 76 / 502 |
intestine | 80% | 259.69 | 773 / 966 | 6% | 0.13 | 31 / 527 |
breast | 77% | 203.51 | 353 / 459 | 8% | 0.19 | 89 / 1118 |
uterus | 65% | 176.51 | 111 / 170 | 16% | 0.51 | 74 / 459 |
adrenal gland | 58% | 131.71 | 149 / 258 | 19% | 0.81 | 44 / 230 |
heart | 60% | 548.47 | 515 / 861 | 0% | 0 | 0 / 0 |
stomach | 47% | 119.36 | 167 / 359 | 9% | 0.20 | 27 / 286 |
skin | 47% | 116.30 | 855 / 1809 | 7% | 0.27 | 31 / 472 |
pancreas | 4% | 6.66 | 12 / 328 | 39% | 0.84 | 70 / 178 |
spleen | 13% | 23.12 | 32 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.26 | 4 / 45 |
muscle | 4% | 8.54 | 35 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
peripheral blood | 0% | 0.47 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097623 | Biological process | potassium ion export across plasma membrane |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0015271 | Molecular function | outward rectifier potassium channel activity |
GO_0005228 | Molecular function | intracellular sodium-activated potassium channel activity |
GO_0005524 | Molecular function | ATP binding |
GO_0070089 | Molecular function | chloride-activated potassium channel activity |
Gene name | KCNT2 |
Protein name | KCNT2 protein (Potassium sodium-activated channel subfamily T member 2) Potassium sodium-activated channel subfamily T member 2 Potassium channel subfamily T member 2 (Sequence like an intermediate conductance potassium channel subunit) (Sodium and chloride-activated ATP-sensitive potassium channel Slo2.1) Sodium activated potassium channel |
Synonyms | SLICK |
Description | FUNCTION: Outward rectifying potassium channel. Produces rapidly activating outward rectifier K(+) currents. Activated by high intracellular sodium and chloride levels . Channel activity is inhibited by ATP and by inhalation anesthetics, such as isoflurane (By similarity). Inhibited upon stimulation of G-protein coupled receptors, such as CHRM1 and GRM1 . . |
Accessions | ENST00000367433.9 [Q6UVM3-2] V9GZ63 Q6UVM3 A0A3B3IRL4 ENST00000647658.1 ENST00000709528.1 [Q6UVM3-2] ENST00000673703.1 A9LNM6 ENST00000466914.2 A0A669KBD9 ENST00000294725.14 [Q6UVM3-1] ENST00000709532.1 [Q6UVM3-1] ENST00000451324.6 ENST00000709531.1 [Q6UVM3-3] ENST00000609185.5 [Q6UVM3-3] Q3SY61 |